Stay updated on Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision indicator changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T21:57:25.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T22:11:28.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study page is now a 403 error, removing the previous study details and replacing them with a 403 Forbidden message and a Home link.
    Difference
    19%
    Check dated 2026-09-23T21:43:54.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows revision: v3.7.0 in place of the previous v3.6.6. This reflects a software update to the site's underlying revision.
    Difference
    0.1%
    Check dated 2026-09-16T22:01:53.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a minor metadata update to the study record page. This reflects a background editorial/update rather than changes to the study data or eligibility.
    Difference
    0.1%
    Check dated 2026-09-02T19:23:32.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-08-12T08:40:55.000Z thumbnail image

Stay in the know with updates to Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.